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Inflammatory infiltrate in invasive lobular and ductal carcinoma of the
breast
AHS Lee, LC Happerfield, RR Millis and LG Bobrow
Hedley Atkins Pathology Laboratory, Imperial Cancer Research Fund Clinical Oncology Unit, Second Floor, New Guy's House,
Guy's Hospital, London SE1 9RT, UK.
Summary The significance of inflammation in carcinoma of the breast is controversial. Little attention has
been paid to different patterns of inflammation or inflammation associated with different histological types of
carcinoma. We have looked at the pattern of inflammation in 123 invasive mammary carcinomas (including 46
lobular), and characterised the inflammatory cells with immunohistochemistry in 21. We found different
patterns of inflammation in ductal and lobular carcinoma. Diffuse inflammation was seen more in ductal
carcinoma, particularly of high grade, and was predominantly composed of macrophages and T cells. It was
associated with necrosis, but the correlation was weak, suggesting that other factors are important. Perilobular
inflammation was seen most frequently in lobular and high-grade ductal carcinomas, particularly at the tumour
edge. Perivascular inflammation was also largely at the tumour edge, but was not more common in any tumour
type. In contrast to the diffuse inflammation, the perivascular and perilobular inflammation was composed ofT
and B cells. Normal lobules at the tumour edge showed consistent expression of HLA-DR, whereas lobules
away from the tumour were negative. A combination of perilobular and perivascular inflammation composed
of B and T cells with epithelial expression of HLA-DR mimicking lymphocytic lobulitis was seen more
frequently in lobular than ductal carcinoma.
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lymphocytic lobulitis
The inflammatory infiltrate in mammary carcinoma has been
investigated for over 70 years (Underwood, 1974), but its
significance remains controversial. Recent in vitro experiments
show that tumour-infiltrating lymphocytes have little or no
cytotoxic activity against autologous tumour (Balch et al.,
1990), and that their function may be inhibited by tumour
cells (Miescher et al., 1986). On the other hand, inflammatory
cells are a potentially important source of cytokines that may
affect angiogenesis and of enzymes that digest the extra-
cellular matrix and thus may affect tumour growth and
metastasis. Different studies, even with multivariate analysis,
have shown that intense inflammation in the tumour is
associated with good prognosis (Rilke et al., 1991), poor
prognosis (Parl et al., 1982) or of no effect (Alderson et al.,
1971; Roses et al., 1982). Most studies have used a general
measure of the amount of inflammation in the tumour and
not attempted to look at different patterns of inflammation.
The inflammatory infiltrate has been characterised using
immunohistochemistry, but frozen sections have been used,
and usually only the inflammation within the tumour has
been studied. Few studies have compared inflammation in
different histological types of carcinoma.
This study was prompted by our impression that the
inflammation associated with invasive lobular carcinoma may
resemble lymphocytic lobulitis. This was reinforced by a case
report describing this association (Chetty and Butler, 1993).
Lymphocytic lobulitis is a recently recognized disorder of the
breast characterised by perilobular and perivascular aggre-
gates of B and T lymphocytes with increased expression of
class II major histocompatibility antigens by the lobular and
ductal epithelium (Lammie et al., 1991; Schwartz and
Strauchen, 1990). We have therefore compared the patterns
of inflammation in invasive ductal and lobular carcinomas,
both within the tumours and in the adjacent breast tissue.
Method
A total of 123 invasive carcinomas of the breast were
studied consisting of two groups. Group 1 was composed of
73 consecutive patients with invasive carcinoma of all types
seen over 6 months (January 1991-June 1991). Group 2
contained 50 consecutive patients with carcinomas showing
features of invasive lobular carcinoma or mixed lobular and
ductal carcinoma, selected from 349 invasive carcinomas
seen over the subsequent 2 year period (July 1991-June
1993).
All patients were operated on and followed up in the
Imperial Cancer Research Fund Clinical Oncology Breast
Unit at Guy's Hospital. Patients with a previous carcinoma
of the breast, or bilateral mammary carcinoma at
presentation were excluded. The tumours were typed using
Azzopardi's criteria (1979). Tumours were classified as
mixed if there was more than 10% of at least two tumour
types. The following were recorded for each tumour:
necrosis in the invasive tumour, invasion of lymphatics or
blood vessels, the number of axillary lymph nodes examined
and the number of these involved by tumour, tumour size
(measured microscopically in tumours up to 20 mm across,
and macroscopically in larger tumours). Only ductal
carcinomas were graded using the modified Bloom and
Richardson method (Elston and Ellis, 1991). The inflamma-
tion was assessed in the first surgical specimen in patients
undergoing more than one procedure, to avoid inflammation
associated with previous surgery. The pattern of inflamma-
tory infiltrate (a) within and (b) at the edge of the invasive
tumour was noted as (i) diffuse in the stroma between
tumour cells, or focal, (ii) around tumour islands, (iii)
around vessels or (iv) around lobules. The intensity of each
pattern of inflammatory infiltrate was graded as absent or
minimal (0), mild (1), moderate (2) or marked (3). The
intensity of inflammation around any carcinoma in situ, and
the presence of inflammation elsewhere in the specimen was
noted.
Comparisons between groups were made with the Mann-
Whitney U-method, and correlation using Spearman's rank
method. The Wilcoxon signed-rank test was used to analyse
paired data.
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1996Immunohistochemistry
Immunohistochemistry with a panel of antibodies and
appropriate pretreatment (Table I) was performed on 21
tumours with a moderate or marked inflammatory infiltrate
(12 lobular, eight ductal (one grade I, two grade II and five
grade III), one mixed lobular and ductal). A streptavidin-
biotin technique was used. Phenol formalin-fixed, paraffin-
embedded sections (3 scm) were dried briefly at room
temperature then at 56°C for 12-18 h. The sections were
dewaxed in xylene, then put into absolute alcohol.
Endogenous peroxidase was inhibited with freshly prepared
0.5% hydrogen peroxide in methanol for 10-15 min.
Sections were then washed in running tap water for 5 min,
and covered with two changes of tris-buffered saline (TBS)
pH 7.6 for 5 min each. The sections were then drained and
covered with primary antibody (diluted in TBS) for 30 min.
After rinsing in TBS, the sections were covered with
biotinylated secondary antibody for 30 min (appropriately
diluted in TBS, and incorporating 1:25 dilution of normal
human serum). After further rinsing with TBS, streptavidin
horseradish peroxidase (appropriately diluted in TBS) was
applied for 30 min. Then after rinsing with TBS, the sections
were covered with freshly prepared diaminobenzidine
solution for 10 min. Finally the sections were washed in
TBS followed by running tap water for 5 min, counterstained
with Mayer's haematoxylin for 2-5 min; rinsed in running
tap water, differentiated in 1% acid-alcohol and 'blued' in
running tap water. Before application of the primary
antibodies to CD3 and von Willebrand factor, swine serum
diluted 1: 5 was applied for 15 min.
Trypsinisation, if required, was performed before applica-
tion of the primary antibody using 0.1% trypsin solution
(with 0.1% calcium chloride; pH 7.8) at 37°C. Immediately
after trypsin treatment the sections were washed in running
tap water for 5 -10 min. Sections for microwave pretreatment
were cut onto Vectabond-coated slides and dried overnight at
56°C. The slides were put in citrate buffer (2.1 g mono-
hydrate citric acid per litre of distilled water, then adjusted to
pH 6.0 with 1 N sodium hydroxide) and microwaved for
multiples of 7.5 min, topping up the buffer between
treatments. After cooling in running tap water for 10 min
the sections were put in TBS, then staining started as above.
lB5 gives good staining on frozen sections, but staining on
paraffin sections with no pretreatment can be weak. We have
obtained good results with 1B5 on paraffin sections with
microwave pretreatment. Before this study, to validate
staining with microwave pretreatment, we compared it with
1B5 staining on frozen sections, and also with two other
antibodies to class II major histocompatibility antigens,
WR18 and LN3, on frozen sections. For this purpose frozen
and paraffin sections from the following mammary specimens
were used: three normal, one lactating, five tumour with
adjacent normal breast, one lymphocytic lobulitis. Concor-
dant expression on endothelium, inflammatory cells, lobular
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and ductal epithelium and tumour was seen. There was
stronger staining on frozen sections. There was minimal
background staining with WR18, whereas there was a little
more with lB5.
For the tumours in this study the staining with 1B5 (with
microwave pretreatment) in the carcinoma and adjacent
breast was compared with sections of normal breast
[uninvolved quadrants from mastectomies of patients in this
series (four), and normal breast included in excision biopsies
for benign disease (six)], lactating breast (two) and
lymphocytic lobulitis (one).
Results
The median age of the patients studied was 57 (range 27-87).
An axillary clearance was performed in 115 patients with a
median of 22 axillary lymph nodes examined (range 8-50). A
median of four sections of tumour were examined (range 1-
12).
The 123 invasive carcinomas of the breast were typed and
graded as follows: Group 1, 55 ductal (15 grade I, 25 grade
II, 15 grade III), eight lobular, four tubular or cribriform,
five mixed lobular and ductal, one mucoid; and group 2, 38
invasive lobular carcinoma and 12 mixed lobular and ductal
carcinomas. In the subsequent analyses invasive tubular and
cribriform carcinomas were grouped with invasive ductal
grade I.
Normal breast
There was minimal inflammation around normal breast ducts
and lobules away from the tumour, for example in the
quadrant sections in mastectomies.
Diffuse inflammation associated with tumour
The predominant pattern of inflammation within and at the
edge of tumours was diffuse in the stroma between tumour
cells (Table II). In all tumour types the intensity of
Table II Intensity ofdiffuse inflammation within and at the edge of
123 invasive carcinomas
Intensity of inflammation
Within tumour Edge of tumour
Tumour type 0 1 2 3 0 1 2 3
Ductal grade I 15 4 13 6
Ductal grade II 11 8 6 9 10 5 1
Ductal grade III 3 5 6 1 1 4 8 2
Lobular 35 10 1 30 15 1
Mixed lobular and ductal 9 8 7 10
Mucinous 1 1
Total 74 35 13 1 60 46 14 3
Table I Panel of antibodies
Pretreatment
Antibody Clonality CD Specificity Dilution (min) Source
CD3 Poly CD3 T cells 1/100 Microwave (30) Dako
CD8/144B Mono CD8 T suppressor cells 1/2 Microwave (30) Dr D Mason, Oxford
UCHL1 Mono CD45RO Primed T helper cells, Neat Professor PCL Beverley,
macrophages, B cells ICRF London
SN130 Mono CD45RA Naive T helper cells, Neat Dr G Janossy, Royal
macrophages, B cells Free Hospital, London
L26 Mono CD20 B cells 1/100 Microwave (15) Dako
PGM1 Mono CD68 Macrophages 1/100 Trypsin (10) Dako
KP1 Mono CD68 Macrophages, granulocytes 1/100 Trypsin (10) Dako
TAL-lB5 Mono -c-chain of HLA-DR Neat Microwave (15) ICRF London
von Willebrand factor Poly Endothelium 1/500 Trypsin (10) Dako
CAM5.2 Mono Low molecular weight 1/10 Trypsin (10) ICRF London
cytokeratinInflammation in mammary carcinoma
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inflammation at the edge was similar to or more than that
within the tumour (Wilcoxon statistic 210, P=0.001). Diffuse
inflammation within the tumour was more marked in the
invasive ductal carcinomas than in invasive lobular
carcinomas (P=0.002, Mann-Whitney U). There was
increasing intensity of inflammation with increasing grade
of ductal carcinoma (p=0.50, P=0.00002). Lobular carcino-
mas had an intensity of inflammation similar to grade I
ductal carcinomas, and significantly less than grade II
(P=0.003) and grade III ductal carcinomas (P<0.0001).
Mixed ductal and lobular carcinomas had an intensity of
inflammation similar to grade I and II ductal carcinomas,
and significantly less than grade III ductal carcinomas
(P=0.005). Diffuse inflammation at the edge of the tumour
and diffuse inflammation within the tumour showed similar
relationships with tumour type and grade.
The presence of tumour necrosis was associated with more
intense diffuse inflammation within the tumour in ductal
carcinoma (p=0.31, P=0.009), but not in mixed carcinoma
(p=0.18) or lobular carcinoma (p=0.18). The intensity of
diffuse inflammation at the tumour edge was associated with
the presence of necrosis in lobular carcinoma (p =0.36,
P=0.007) as well as in ductal carcinoma (p=0.29). The
proportion of ductal carcinomas with tumour necrosis
increased with grade (p=0.51, P=0.00002).
Focal inflammation
Focal inflammation around tumour cells was uncommon. It
was seen within only six tumours (two ductal, two lobular
and two mixed ductal and lobular), and at the edge of 11
tumours (six ductal, three lobular and two mixed ductal and
lobular).
Perilobular inflammation
In all histological tumour types perilobular inflammation was
more marked at the edge than within the tumour (Table III;
Wilcoxon statistic 570, P<0.001). The intensity of perilob-
ular inflammation at the tumour edge was more marked in
lobular than ductal carcinomas (P=0.02, Mann-Whitney
U). Perilobular inflammation increased with increasing grade
of ductal carcinoma (p =0.28, P=0.02). The intensity of
perilobular inflammation at the edge of invasive carcinomas
decreased with the age of the patient in ductal carcinomas
(p=-0.53, P= 10-5), and mixed ductal and lobular
carcinomas (p=-0.47, P=0.03), but not in lobular
carcinoma (p =-0.08). When moderate or marked perilob-
ular inflammation was seen in ductal carcinomas there was
usually moderate diffuse inflammation within the tumour. By
contrast in lobular carcinomas with moderate or marked
perilobular inflammation there was usually little or no diffuse
inflammation within the tumour (Table IV).
Perivascular inflammation
Perivascular inflammation was more marked at the edge than
within tumours (Wilcoxon statistic 1443, P<0.001), but was
not significantly more common in any histological type of
tumour, or in any grade of ductal carcinoma. In ductal
carcinomas with moderate or marked perivascular inflamma-
tion there was usually moderate diffuse inflammation within
the tumour. By contrast in lobular carcinomas with moderate
or marked perivascular inflammation there was usually little
or no diffuse inflammation within the tumour (see Table V
and Figures 1 and 2). The intensity of perilobular
inflammation at the tumour edge correlated with the
intensity of perivascular inflammation adjacent to the
tumour in lobular (p=0.68, P< 10-5), but not in ductal
(p = -0.07) or mixed carcinomas (p =0.07). The combination
of moderate or marked perilobular inflammation, with mild,
moderate or severe perivascular inflammation was seen in 8
of 46 (17%) lobular carcinomas and 2 of 59 (3%) ductal
carcinomas (P=0.02, Fisher exact test).
In situ carcinoma
The intensity of inflammation around any in situ carcinoma
component correlated with the intensity of diffuse inflamma-
tion within the invasive component of ductal carcinomas
(p =0.50, P=0.00005), and mixed ductal and lobular
carcinomas (p=0.54, P=0.01), but not of lobular carcino-
mas (p=0.08). In invasive ductal carcinomas the intensity of
inflammation around in situ carcinoma increased with the
grade of the invasive component (p=0.36, P=0.003).
No relationship was found between axillary nodal status
and diffuse, perivascular or perilobular inflammation in
invasive carcinoma. However, the intensity of inflammation
around carcinoma in situ correlated with the number of
Table V Intensity of diffuse inflammation in carcinomas with
moderate or marked perivascular inflammation at the edge
Intensity of diffuse inflammation
Tumour type 0 1 2 3
Invasive ductal 2 4 1
Invasive lobular 8 1
P=0.001 (Mann-Whitney).
Table HII Intensity of perilobular inflammation within and at the
edge of 123 invasive carcinomas
Intensity of inflammation
Within tumour Edge of tumour
Tumour type 0 1 2 3 0 1 2 3
Ductal grade I 18 1 17 2
Ductal grade II 23 1 1 20 3 2
Ductal grade III 15 9 3 3
Lobular 44 2 30 7 7 2
Mixed lobular and ductal 17 14 1 2
Mucinous 1 1
Total 118 2 3 90 17 14 2
Table IV Intensity of diffuse inflammation in carcinomas with
moderate or marked perilobular inflammation at the edge
Intensity ofdiffuse inflammation
Tumour type 0 1 2 3
Invasive ductal 1 4
Invasive lobular 5 3 1
P=0.01 (Mann-Whitney)
Figure 1 Invasive lobular carcinoma with a circumscribed
perivascular cluster of inflammatory cells, but minimal inflamma-
tion within the tumour. Haematoxylin and eosin.involved axillary lymph nodes in ductal carcinoma (p= 0.42,
P=0.0008) especially grade III (p=0.81, P=0.0003), but not
in lobular carcinoma (p = 0.004).
Immunohistochemistry
In the normal breast there was minimal inflammation, with
small numbers of T cells (including CD8+) and macrophages
around and within the epithelium of lobules and ducts. Only
a very occasional B cell was seen within the lobular
epithelium.
The diffuse inflammation within tumours was predomi-
nantly composed of T cells and macrophages. There tended
to be more macrophages than T cells, particularly in lobular
carcinoma. Only small numbers of B cells were present.
CD45RO+ cells usually outnumbered CD45RA+ cells. The
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perilobular and perivascular inflammation by contrast was
composed of similar numbers of B and T cells, with few
macrophages (see Figure 2). There were similar numbers of
CD45RO+ and CD45RA+ cells.
Expression of HLA-DR was assessed in ten sections of
normal non-lactating breast: 1B5 stained some lymphocytes
in ductal and lobular epithelium, and vessels adjacent to
lobules and ducts (confirmed with staining for leucocyte
common antigen and von Willebrand factor). In three
biopsies there was weak epithelial staining (patchy staining
of inner epithelial cells), and in one further biopsy there was
stronger epithelial staining (all epithelial cells in lobule or
duct positive). In addition, both biopsies of lactating breast
showed uniform strong epithelial staining. In the one biopsy
of lymphocytic lobulitis there was patchy epithelial staining,
weak in some areas and strong in others. There was staining
of normal lobules and ducts adjacent to all 19 tumours where
normal breast was present (8 weak, 11 strong) see Figure 3.
Epithelial expression of HLA-DR was sometimes, but not
always, associated with perilobular inflammation.
Discussion
The role of inflammation in tumours is controversial. Studies
of the prognostic significance of inflammation in carcinoma
of the breast, even with multivariate analysis, have produced
conflicting results. A potential explanation of this is that few
-.1iCi" .
Figure 2 Invasive ductal carcinoma showing inflammation both
within the tumour and around an adjacent lobule. (a) There are T
cells (CD3) both within the tumour and around the adjacent
lobule. (b) B cells (CD20) are largely confined to around the
lobule. (c) Macrophages (CD68) are seen within the tumour and
to a lesser extent around the adjacent lobule. All the same
magnification.
Figure 3 HLA-DR expression shown with lB5 is seen (a) in
vessels and around some acini of the normal lobule. (b) It is
present weakly on the ductal carcinoma cells, and more strongly
on inflammatory cells within the tumour, and on the adjacent
lobules. Both the same magnification.Inflammation in mammary carcinoma
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previous studies have looked at the pattern of inflammation
in tumours.
In invasive carcinomas we found that diffuse inflammation
in the stroma between tumour cells was the predominant
pattern of inflammation. Most studies do not distinguish
between different patterns of inflammation and use a general
score, which probably in most tumours is similar to what we
describe as diffuse inflammation. We found more intense
inflammation in ductal than lobular carcinoma in agreement
with the only large series that looked at inflammation in
different histological types (Aaltoma et al., 1992). Increasing
inflammation with increasing histological grade has also been
found by others (Aaltoma et al., 1992; Black et al., 1975;
Elston et al., 1982; Fisher et al., 1983; Kurtz et al., 1990).
Most, but not all, studies have noted an association between
inflammation and necrosis (Fisher et al., 1975; Black et al.,
1975; Fisher et al., 1983; Aaltoma et al., 1992; An et al., 1987).
We found diffuse inflammation, histological grade and
necrosis were interrelated in ductal carcinomas, but the
correlation between the diffuse inflammation and necrosis
was weak (p=0.31) so there must be factors in addition to
necrosis causing the inflammation. The reported associations
of inflammation with tumour expression of c-erbB-2 (Rilke et
al., 1991) and colony-stimulating factor 1 (Scholl et al., 1994)
are of potential interest. Immunohistochemistry showed that
the diffuse inflammation in tumours was predominantly
composed of T cells and macrophages. The majority of other
studies have found that T cells outnumbered macrophages (An
et al., 1987; Bhan and DesMarais, 1983; Giorno, 1983;
Hurliman et al., 1985; von Kleist, 1987; Zuk and Walker,
1987), but a significant minority, like us, found more
macrophages than T cells (Gottlinger et al., 1985; Horny et
al., 1986; van Ravenswaay et al., 1992). Few B cells and few or
no natural killer cells are consistent findings in the literature.
Focal inflammation close to and within tumour nests was
uncommon in all tumour types in agreement with other series
(Bhan et al., 1983; Gottlinger et al., 1985; Lwin et al., 1985).
It has been suggested that this low frequency ofinflammatory
cells close to the tumour cells indicates that the lymphocytes
and macrophages do not represent an immune response to
the tumour cells.
Perilobular inflammation was rarely seen within the
tumour, probably owing to destruction of normal structures
by the tumour. Black and Speer (1955) found marked
inflammation in the tumour was associated with perilobular
inflammation. They made no comment on histological tumour
types, but the pattern described is similar to our findings in
ductal carcinomas. By contrast in lobular carcinomas with
perilobular inflammation there was usually little or no diffuse
inflammation within the tumour. Immunohistochemistry
showed that, in contrast to the diffuse inflammation, the
perilobular inflammation was predominantly composed of B
and T cells with few macrophages.
The relative absence of perivascular inflammation within
the tumour may be because of differences between vessels
within the tumour and normal vessels at the edge. There is
evidence of differences between the endothelium in mammary
carcinomas and in normal breast (Hagemeier et al., 1986;
Wang et al., 1993). Perivascular inflammation in breast
cancer has been little studied. Black et al. (1975) found
perivenous inflammation was associated with poorly differ-
entiated tumours and longer survival in univariate analysis. It
has been suggested that perivascular inflammation is a
reflection of cell-mediated immunity by analogy with the
changes in delayed type hypersensitivity reactions in the skin
(Dvorak et al., 1981). The perivascular inflammation, like the
perilobular inflammation, was predominantly composed of B
and T cells with few macrophages.
Normal breast epithelium shows no expression of HLA-
DR (Bartek et al., 1987; Lucin et al., 1994), except during
late pregnancy and lactation (Bartek et al., 1987). We found
consistent staining for HLA-DR in lobules adjacent to
carcinomas, in agreement with Bartek et al. (1987), who
found focal staining for HLA-DR in normal epithelium
adjacent to 70% of carcinomas. Lucin et al. (1994),
however, found no such staining of the normal breast 'in
the vicinity' of carcinomas. Epithelial expression of HLA-
DR was in some tumours associated with perilobular
inflammation.
A combination of perivascular and perilobular inflamma-
tion mimicking lymphocytic lobulitis was much more
common in lobular (17%) than ductal carcinomas (3%). As
well as the distribution of the inflammation, the immuno-
phenotype of the inflammatory cells (B and T cells) and
epithelium (HLA-DR expression) are similar to lymphocytic
lobulitis. Lymphocytic lobulitis is thought to be an
autoimmune disorder, but the mechanism of the inflamma-
tory changes is not understood. The fact that in mammary
carcinoma perilobular and perivascular inflammation were
almost always only seen within or adjacent to the carcinoma,
and that similar patterns may be seen associated with
metastases (Lee et al., 1995) suggest that the inflammation
is related to the tumour. In ductal carcinomas with
perivascular or perilobular inflammation there was usually
moderate diffuse inflammation within the tumour. By
contrast, in lobular carcinomas with perivascular or
perilobular inflammation there was usually little or no
diffuse inflammation within the tumour.
The intensity ofinflammation around the carcinoma in situ
correlated with the diffuse inflammation within invasive
ductal carcinomas and with the grade of the invasive ductal
carcinoma. Black et al. (1975) also found a correlation
between the inflammation around the in situ and invasive
carcinoma. This is consistent with more intense inflammation
in high-grade ductal carcinoma in situ (Ramachandra et al.,
1990) as in invasive ductal carcinoma, and that the grade of
in situ and infiltrating components correlate with each other
(Lampejo et al., 1994).
There are conflicting results from studies of inflammation
and tumour stage (Aaltoma et al., 1992; Lucin et al., 1994;
Lauder et al., 1977; Syrjanen et al., 1978; Bhan and
DesMarais, 1983). We did not find any relationship between
inflammation within or at the edge of the invasive tumour
and stage, but the intensity of inflammation around
carcinoma in situ correlated with the number of involved
axillary lymph nodes in ductal carcinomas, particularly
grade III. This is difficult to explain and may be a chance
result.
Some studies have found more inflammation in the
tumours of younger women (Fisher et al., 1975; Kurtz et
al., 1990). We found less perilobular inflammation in older
women with ductal and mixed ductal and lobular carcinomas,
consistent with lobular atrophy, but interestingly this pattern
was not seen in lobular carcinoma. Other patterns of
inflammation were not related to age.
In conclusion, we have found different patterns of
inflammation composed of different cell types with different
frequencies in ductal and lobular carcinomas. They may have
different functional significance. The conflicting findings in
prognostic studies ofinflammation in carcinoma of the breast
may in part be due to failure to recognise these different
patterns of inflammation. There is increasing interest in
immunotherapy as a treatment for carcinoma of the breast,
and an understanding of inflammation, including the
significance of the different patterns, in mammary carcinoma
is potentially important.hduNs- n mumumy cuci--a
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